Shopping Cart
- Remove All
- Your shopping cart is currently empty
Atrial natriuretic factor (1-28) (human, porcine) TFA exhibits antihypertensive activity by promoting sodium and urine excretion. It inhibits the release of adrenocorticotropic hormone (ACTH) and β-endorphin by suppressing pro-opiomelanocortin (POMC) expression. Additionally, it elevates cGMP levels in RMIC cells, with an IC50 of 1.2 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $125 | 7-10 days | |
5 mg | Preferential | 7-10 days |
Description | Atrial natriuretic factor (1-28) (human, porcine) TFA exhibits antihypertensive activity by promoting sodium and urine excretion. It inhibits the release of adrenocorticotropic hormone (ACTH) and β-endorphin by suppressing pro-opiomelanocortin (POMC) expression. Additionally, it elevates cGMP levels in RMIC cells, with an IC50 of 1.2 nM. |
Alias | Atrial natriuretic peptide (1-28) TFA, Atrial natriuretic factor (1-28) (human, porcine) TFA |
Molecular Weight | 3080.46 (free base) |
Formula | C127H205N45O39S3.xC2HF3O2 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.